Dechra Pharmaceuticals Q1 trading stronger than expected

Dechra Pharmaceuticals said on Tuesday that first-quarter trading has been stronger than expected.

In a very brief statement ahead of its annual meeting, the veterinary pharmaceuticals specialist also cautioned that at this early stage of the year, the ongoing effect of the Covid-19 pandemic on its markets is "not yet certain".

Dechra is due to release its results for the six months to 31 December on 22 February 2021.